Baxter International Inc. (BAX) financials: revenue, earnings and cash flow
Fiscal 2018–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Baxter International’s revenue went from $11.1B in fiscal 2018 to $11.2B in fiscal 2025, growth of about 0.2% a year.
Net income in fiscal 2025 was -$957M, a net margin of -8.5%; the best year in this period was 2023 with $2.7B.
Over the twelve months to September 30, 2026, revenue was $11.6B and net income -$723M.
Free cash flow was $332M in fiscal 2025 and positive in 8 of the 8 years shown.
The diluted share count fell 6% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6B | $11.2B | $10.6B | $10.4B | $10.1B | $12.1B | $11.7B | $11.4B | $11.1B |
| Gross profit | $3.5B | $3.4B | $4.0B | $4.2B | $3.5B | $4.7B | $4.6B | $4.8B | $4.8B |
| Operating income | -$221M | -$308M | $14M | $707M | -$2.8B | $1.4B | $1.6B | $1.8B | $1.6B |
| Net income | -$723M | -$957M | -$649M | $2.7B | -$2.4B | $1.3B | $1.1B | $1.0B | $1.5B |
| EPS (diluted) | $-1.42 | $-1.87 | $-1.27 | $5.23 | $-4.83 | $2.53 | $2.13 | $1.93 | $2.83 |
| R&D | $519M | $518M | $590M | $518M | $450M | $531M | $521M | $595M | $654M |
| Revenue growth | — | +5.7% | +2.7% | +3.0% | −17.2% | +4.0% | +2.7% | +2.4% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.6B | $845M | $1.0B | $1.7B | $1.2B | $2.2B | $1.9B | $2.1B | $2.0B |
| Capital spending | -$506M | -$513M | -$446M | -$432M | -$377M | -$691M | -$709M | -$696M | -$659M |
| Free cash flow | $1.1B | $332M | $573M | $1.3B | $834M | $1.5B | $1.2B | $1.4B | $1.4B |
| Dividends paid | $102M | $348M | $590M | $586M | $573M | $530M | $473M | $423M | $376M |
| Buybacks | — | — | $0 | $0 | $32M | $600M | $500M | $1.3B | $2.5B |
| Stock-based pay | $110M | $117M | $114M | $115M | $140M | $146M | $130M | $122M | $115M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $2.0B | $1.8B | $3.1B | $1.6B | $3.0B | $3.7B | $3.3B | $1.8B |
| Debt | — | $9.8B | $13.4B | $14.1B | $17.2B | $18.3B | $6.8B | $5.7B | $3.5B |
| Equity | — | $6.1B | $7.0B | $8.4B | $5.8B | $9.1B | $8.7B | $7.9B | $7.8B |
| Total assets | — | $20.1B | $25.8B | $28.3B | $28.3B | $33.5B | $20.0B | $18.2B | $15.7B |
| Shares (diluted) | 520M | 513M | 510M | 508M | 504M | 508M | 517M | 519M | 546M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 30.1% | 30.0% | 37.5% | 40.1% | 35.3% | 38.9% | 39.3% | 41.9% | 42.9% |
| Operating margin | -1.9% | -2.7% | 0.1% | 6.8% | -28.3% | 11.1% | 13.8% | 15.6% | 14.3% |
| Net margin | -6.2% | -8.5% | -6.1% | 25.6% | -24.2% | 10.6% | 9.4% | 8.8% | 13.9% |
| FCF margin | 9.8% | 2.9% | 5.4% | 12.5% | 8.3% | 12.6% | 9.9% | 12.4% | 12.2% |
| ROIC | — | -1.5% | 0.1% | 2.4% | -11.8% | 4.6% | 9.0% | 10.3% | 13.4% |
| ROE | — | -15.6% | -9.3% | 31.6% | -41.7% | 14.1% | 12.7% | 12.7% | 19.7% |
Frequently asked questions
What is Baxter International’s annual revenue?
$11.2B in fiscal 2025 and $11.6B over the twelve months to September 30, 2026.
How much profit does Baxter International make?
Net income was -$957M in fiscal 2025 (net margin -8.5%).
Is Baxter International’s revenue growing?
Yes: revenue rose 5.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.